Paragon Bioservices, a private equity-backed biologics CDMO with expertise in gene therapy and next-generation vaccines, has opened its new, state-of-the-art 200,000 square-foot GMP gene therapy biomanufacturing facility in Anne Arundel County, MD. The new facility is equipped with several 500L and 2000L single-use bioreactors for clinical through commercial material production. Paragon has GMP projects underway for leading gene-therapy biopharmaceutical companies. “The grand opening to...